How European and U.S. Genetic Engineering Scientists View the Impact of Public Attention on Their Field: A Comparison
- 1 January 1994
- journal article
- research article
- Published by SAGE Publications in Science, Technology, & Human Values
- Vol. 19 (1) , 23-46
- https://doi.org/10.1177/016224399401900103
Abstract
Two recent surveys of genetic engmeering scientists have assessed how scientists in the United States and in Europe view the influence of regulation and public attention on recombinant DNA research. Generally, European researchers are more negative about this issue: they feel that public attention has hampered progress in the field more than it has helped it. The probable cause for this difference is that European countries tend to have more—and more stringent—regulations on bioengineering than the United States, although there are also national differences in the climate for bioengineering research. On the other hand, scientists in the United States seem extremely concerned about competitiveness, especially relative to Japan.Keywords
This publication has 27 references indexed in Scilit:
- The Euro-Postdoc: National Barriers Are CrumblingScience, 1992
- Is the United States Losing its Lead?Science, 1992
- Swiss vote for biotechnology, with controlsNature, 1992
- Swiss Drug Giants Seek Antidote to ActivistsScience, 1992
- Science in EuropeScience, 1992
- Germany's Gene Law Begins to BiteScience, 1992
- How Europe Regulates Its GenesScience, 1991
- Greens losing gene battleNature, 1990
- Europe falling behindNature, 1990
- German Biotech Firms Flee Regulatory ClimateScience, 1989